Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-31

Clinical Trial Update: Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of berberine-containing triple therapy for first-line eradication of Helicobacter pylori and its impact on chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine-containing triple therapy (berberine-containing triple therapy)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Helicobacter Pylori Infection, Chronic Gastritis | Phase 4 | Status: COMPLETED